Medical debt linked to higher late-stage cancer rates

Lung cancer showed the strongest absolute association, while prostate and breast cancer findings diverged from the broader pattern.

By
Andrea Surnit
October 9, 2026
4 min

MDSpire News

Overview

In a county-level analysis of 2,958 US counties, higher prevalence of medical debt in collections was associated with higher late-stage incidence for 7 of 9 evaluated cancer types. The largest absolute association was for lung cancer; the ecological, cross-sectional design does not establish causation or patient-level relationships.

Background

Medical debt is a financial burden for many people with cancer and may coexist with delays or forgone care, as described in related reporting. The study examined whether county-level medical debt prevalence was associated with cancer incidence and stage at diagnosis, given the relevance of early detection and screening to cancer control. Researchers assessed 9 cancers with screening recommendations or recognizable early signs or symptoms. The analysis used county-level data and therefore cannot determine whether individuals with debt were the same people diagnosed with cancer.

Data Highlights

Measure	Finding
Study population	2,958 US counties; 185 of 3,143 counties were excluded because medical debt data were unavailable.
Medical debt prevalence	Mean 21% of individuals with credit bureau records had medical debt in collections; county prevalence ranged from 1% to 52%.
Debt and social vulnerability	Mean medical debt prevalence was 27% in counties in the highest Social Vulnerability Index quartile and 14% in the lowest quartile.
Adjusted association per 10-percentage-point increase in debt prevalence	Additional late-stage cases per 100,000 person-years: lung, 5.15; head and neck, 0.92; colorectal, 0.69; melanoma, 0.59; cervical, 0.39; kidney and renal pelvis, 0.38; bladder, 0.24.
Highest vs lowest debt quartile	Late-stage incidence was 39% higher for lung cancer, 14% higher for colorectal cancer, and 24% higher for cervical cancer.
Other cancer findings	Late-stage breast cancer incidence was not associated with debt in the primary analysis, although an association appeared in sensitivity analyses. Higher debt was associated with lower recorded late-stage prostate cancer incidence.

Key Findings

Researchers related medical debt prevalence in 2016 to age-adjusted cancer incidence from 2017 to 2021, defining late-stage disease as regional or distant.
Models adjusted for metropolitan status, primary care physician density, and Social Vulnerability Index, included state-level random effects, and were weighted by county population.
Higher debt prevalence was associated with higher late-stage incidence for lung, head and neck, colorectal, melanoma, cervical, kidney and renal pelvis, and bladder cancers.
Associations were generally consistent in sex-stratified analyses, with larger estimated incidence changes among males; sensitivity analyses using alternative socioeconomic adjustments and available screening rates for colorectal, breast, and cervical cancers produced similar results.
The prostate finding may reflect differences in prostate-specific antigen testing, diagnostic intensity, or staging in communities with fewer resources, rather than lower underlying disease burden; this is an interpretation raised in the source.
The authors noted that ecological and cross-sectional data precluded causal or patient-level conclusions and that residual confounding, within-county disparities, and differences in data availability could affect interpretation.

Clinical Implications

The authors characterized medical debt as a potential area-level marker of structural and financial barriers associated with cancer detection and population-level outcomes. They called for longitudinal studies incorporating individual-level risk factors and health care use to clarify the relationship between medical debt and cancer stage at diagnosis.

Conclusion

County-level medical debt prevalence was associated with higher late-stage incidence for 7 evaluated cancer types, with the largest absolute association observed for lung cancer. The findings are observational and require individual-level and longitudinal investigation to clarify the relationship.